** Brokerage Stephens cuts price target for home health services provider Addus HomeCare ADUS.O to $142 from $153; maintains "overweight" rating
** The new PT represents 45.5% upside to stock's last close
** Brokerage says uncertainty over funding for federal health insurance program Medicaid has been pushing the stock lower as the co's patient population can be impacted
** Stock closed 10.4% lower on Tuesday, and has shed about 22% YTD
** ADUS, however, views its position of low-cost settings serving older adults and disabled population within Medicaid as likely more insulated from the broader potential reductions
** Company, after market close on Monday, posted quarterly adj. profit of $1.38/shr compared with analysts' estimate $1.35/shr, according to data compiled by LSEG
** 11 of 12 brokerages rate the stock "buy" or equivalent, and one "underweight"; their median PT is $138 - data compiled by LSEG
** ADUS rose 33.3% in 2024
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.